🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carmen Camarena

Virginia Commonwealth University

ORCID: 0000-0002-7030-171X

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer”.

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

Research Square(2020)10.21203/rs.2.15818/v2

N/A

0DataRank · unranked

1 citations

Laura Graham, Timothy Smith, Carmen Camarena, Matthew Zellner, Jamie-Jean S Gilmer +5 more

Optimization of high throughput spectral flow cytometry for immune cell profiling in mouse liver

Liver Research(2023)10.1016/j.livres.2023.08.001

N/A

0DataRank · unranked

5 citations

Hongkun Lu, Xuan Wang, Derrick Zhao, Carmen Camarena, Devanand Sarkar +3 more

D-2-Hydroxyglutarate Attenuates Sinonasal Inflammation in Murine Allergic Rhinitis

Allergies(2025)10.3390/allergies5020013

N/A

0DataRank · unranked

1 citations

Ankit Kumar, Carmen Camarena, Daniel H. Conrad, Rebecca Martin, Anuj Tharakan